NeoplasmsNCT06581666
Current Awareness, Perspective and Knowledge on Social Egg Freezing
An observational study of Neoplasms, run by Chinese University of Hong Kong at 1 site in Hong Kong.
Trial summary
Hong Kong's fertility preservation service is underutilized and limited, with low awareness among clinicians and young adults. Traditional Chinese culture may lead to social stigma, preventing discussion of fertility issues. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Neoplasms
- What is being tested?
- No special intervention, all participants will be asked to complete same set of questionnaire.
- How many people
- 200 participants
- Where
- 1 siteHong Kong
- Study dates
- 1 Sep 2024to 1 Sep 2030
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: All patients aged from 18-60 years old, who have undergone or will seek fertility preservation services in PWH and the general public will be invited to participate.
Who may be able to join
- People with aged from 18-60 years old
Who cannot join
- Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Hong Kong1 site, 1 recruiting
- Recruiting
Pui Wah Jacqueline Chung
Hong Kong
PUI WAH JACQUELINE CHUNG, +852 35051537, jacquelinechung@cuhk.edu.hk
Elaine Yee Lee NG, +852 35052745, elaineng@cuhk.edu.hk
About this study
Hong Kong's fertility preservation service is underutilized and limited, with low awareness among clinicians and young adults. Traditional Chinese culture may lead to social stigma, preventing discussion of fertility issues. A survey aims to explore awareness, knowledge, and acceptance of oocyte cryopreservation, enabling resource allocation for a culturally acceptable public education program and a dedicated referral system to improve oocyte cryopreservation services.
Read the detailed description
Hong Kong's fertility preservation service is underutilized and limited, with low awareness among clinicians and young adults. Traditional Chinese culture may lead to social stigma, preventing discussion of fertility issues. A survey aims to explore awareness, knowledge, and acceptance of oocyte cryopreservation, enabling resource allocation for a culturally acceptable public education program and a dedicated referral system to improve oocyte cryopreservation services.
The questionnaire will be in paper form and as an online survey. Potential participants will be provided with the study aim and respondent rights. Once verbal informed consent is obtained, participants will be asked to fill in the self-administered questionnaire. For the online survey, implied consent from the participants will be adopted when they complete the questionnaire on the webpage and return it to us.
In order to reach the 2 target groups, convenient sampling will be used. Questionnaires will be distributed to the patients who have undergone or will seek fertility preservation services in PWH. For the general public, they will be recruited online via an invitation link.
- Conditions
- Neoplasms
- Being tested
- No special intervention, all participants will be asked to complete same set of questionnaire.
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No special intervention, all participants will be asked to complete same set of questionnaire.Other
No special intervention, all participants will be asked to complete same set of questionnaire.
| Study group | Role | What they receive |
|---|---|---|
| All patients who have undergone or will seek fertility preservation services | All patients who have undergone or will seek fertility preservation services, but they will be asked to complete the same set of questionnaires. Receives: Other: No special intervention, all participants will be asked to complete same set of questionnaire. | |
| General public | The general public will also be asked to complete the sane set of questionnaires. Receives: Other: No special intervention, all participants will be asked to complete same set of questionnaire. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Awareness, perspective and knowledge
To evaluate the difference in the level of awareness, perspective and knowledge towards social egg freezing between patients who have undergone or will seek fertility preservation services and the general public.
Measured: through study completion, an average of 1 year
Secondary outcomes (3)
Awareness
To evaluate the awareness of oocyte cryopreservation among the general public and patients
Measured: through study completion, an average of 1 year
Factors that may affect the uptake rate
To determine any factors that may affect the uptake rate of oocyte cryopreservation
Measured: through study completion, an average of 1 year
Utilization rate
To assess the utilization rate of social egg freezing
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Sep 2024
- Study start1 Sep 2024
- Primary completion31 Aug 2029 (estimated)
- Study completion1 Sep 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for NeoplasmsStudies of the same condition, open and under way.
- More trials run by Chinese University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chinese University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Chung Pui Wah Jacqueline, Chinese University of Hong Kong
- Investigators
- PUI WAH JACQUELINE CHUNG, Principal investigator, Chinese University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06581666
- Sponsor's protocol ID
- 2024.346
- Status last verified
- Nov 2024
- First submitted
- 22 Aug 2024
- Last updated
- 12 Nov 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Current Awareness, Perspective and Knowledge on Social Egg Freezing
- ClinicalTrials.gov ID
- NCT06581666
- Acronym / sponsor ID
- 2024.346
- Conditions
- Neoplasms
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Chinese University of Hong KongUniversity, hospital or other
- Study start
- 1 Sep 2024 (actual)
- Primary completion
- 31 Aug 2029 (estimated)
- Study completion
- 1 Sep 2030 (estimated)
- First posted
- 3 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hong Kong's fertility preservation service is underutilized and limited, with low awareness among clinicians and young adults. Traditional Chinese culture may lead to social stigma, preventing discussion of fertility issues. A survey aims to explore awareness, knowledge, and acceptance of oocyte cryopreservation, enabling resource allocation for a culturally acceptable public education program and a dedicated referral system to improve oocyte cryopreservation services.
Detailed description
Hong Kong's fertility preservation service is underutilized and limited, with low awareness among clinicians and young adults. Traditional Chinese culture may lead to social stigma, preventing discussion of fertility issues. A survey aims to explore awareness, knowledge, and acceptance of oocyte cryopreservation, enabling resource allocation for a culturally acceptable public education program and a dedicated referral system to improve oocyte cryopreservation services.
The questionnaire will be in paper form and as an online survey. Potential participants will be provided with the study aim and respondent rights. Once verbal informed consent is obtained, participants will be asked to fill in the self-administered questionnaire. For the online survey, implied consent from the participants will be adopted when they complete the questionnaire on the webpage and return it to us.
In order to reach the 2 target groups, convenient sampling will be used. Questionnaires will be distributed to the patients who have undergone or will seek fertility preservation services in PWH. For the general public, they will be recruited online via an invitation link.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| All patients who have undergone or will seek fertility preservation services | – | Other: No special intervention, all participants will be asked to complete same set of questionnaire.All patients who have undergone or will seek fertility preservation services, but they will be asked to complete the same set of questionnaires. |
| General public | – | Other: No special intervention, all participants will be asked to complete same set of questionnaire.The general public will also be asked to complete the sane set of questionnaires. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- All patients aged from 18-60 years old, who have undergone or will seek fertility preservation services in PWH and the general public will be invited to participate.
Key inclusion criteria (1 listed)
- People with aged from 18-60 years old
Key exclusion criteria (1 listed)
- Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No special intervention, all participants will be asked to complete same set of questionnaire.No special intervention, all participants will be asked to complete same set of questionnaire. | Other | All patients who have undergone or will seek fertility preservation services, General public |
Primary outcome
Awareness, perspective and knowledge
Time frame: through study completion, an average of 1 year
To evaluate the difference in the level of awareness, perspective and knowledge towards social egg freezing between patients who have undergone or will seek fertility preservation services and the general public.
3 secondary outcomes
Awareness
Time frame: through study completion, an average of 1 year
Factors that may affect the uptake rate
Time frame: through study completion, an average of 1 year
Utilization rate
Time frame: through study completion, an average of 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Nov 2024.
- Individual participant dataSharing planned: No
Related trials for Neoplasms
Not yet recruitingPhase 1/2
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Thyroid Cancer
RecruitingPhase 1/2
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
RecruitingPhase 3
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
Ovarian Cancer, Ovarian Neoplasms
RecruitingPhase 1/2
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Lymphoma, Non-Hodgkin Lymphoma
RecruitingPhase 3
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
PUI WAH JACQUELINE CHUNG principal investigator
Chinese University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Neoplasms, run by Chinese University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 12 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact PUI WAH JACQUELINE CHUNG (+852 35051537, jacquelinechung@cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Awareness, perspective and knowledge (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Nov 2024.